Biotron Ltd

(BITRF)

By |

Profile

Biotron Ltd is a biotechnology company. The company is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.

Contact Information

Website: www.biotron.com.au
Main Phone: +61 298050488
Address: 56 Delhi Road
Address 2: Suite 3.3
State: NSW
City / Town: Sydney
Country: AU
Postal Code: 2113

Issuer Information

Exchange: OTO
Employees: 4

Equities News

Profile

Biotron Ltd is a biotechnology company. The company is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.

Contact Information

Website: www.biotron.com.au
Main Phone: +61 298050488
Address: 56 Delhi Road
Address 2: Suite 3.3
State: NSW
City / Town: Sydney
Country: AU
Postal Code: 2113

Issuer Information

Exchange: OTO
Employees: 4

Equities News

$ 0.064 $ 0. (0.00%)
Last Price 0.064 Change $ 0. Change % 0.00 Tick N/A
Bid 0.054 Bid Size 10,000.00 Ask 0.36 Ask Size 2,500.00
Open N/A High N/A Low N/A Prev Close 0.064
Last Trade Volume 0 52 Wk Hi 0.13 52 Wk Low 0.04
Market Cap 44.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 701,932,713.00 EPS (TTM) N/A PE Ratio -16.90 Exchange OTCPK